Document is current
Any future updates will be listed below
-
Authors
Hassett, Michael
Dias, Samira
Cronin, Christine
Schrag, Deborah
McCleary, Nadine
Simpson, Jaclyn
Poirier-Shelton, Tiana
Bian, Jessica
Reich, James
Dizon, Don
Begnoche, Megan
Jenkins, Hannah Hazard
Tasker, Laura
Wong, Sandra
Pearson, Loretta
Paudel, Roshan
Osarogiagbon, Raymond U.
-
Funding
Funding for this research was provided by:
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
National Cancer Institute, United States (UM1CA233080)
- License Information
-
More Information
Article History
Received: 19 January 2024
Accepted: 3 September 2024
First Online: 12 November 2024
Declarations
:
: The Western Institutional Review Board (WIRB) approved the protocol as a minimal risk research study on November 25, 2018 (protocol #20182593) with a waiver of individual authorization for release of health data and a waiver of informed consent.
: Not applicable.
: The authors declare no competing interests.
